Harbin Pharmaceutical Group Co., Ltd. Class ASSE: 600664

Announcement on Subsidiary's Drug Passing the Consistency Evaluation for Generic Drugs

· Issued by Harbin Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Subsidiary's Drug Passing the Consistency Evaluation for Generic Drugs

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment